Analyst Price Target is $12.25
▲ +12.59% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Edap Tms in the last 3 months. The average price target is $12.25, with a high forecast of $14.00 and a low forecast of $11.00. The average price target represents a 12.59% upside from the last price of $10.88.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in Edap Tms. This Buy consensus rating has held steady for over two years.
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.